BIO-key International, Inc. (NASDAQ:BKYI) has a beta value of 1.34 and has seen 3,260,133 shares traded in the last trading session. The company, currently valued at $19.62 Million, closed the last trade at $0.89 per share which meant it gained $0.15 on the day or 21.42% during that session. The BKYI stock price is -189.89% off its 52-week high price of $2.58 and 60.67% above the 52-week low of $0.35. If we look at the company’s 10-day average daily trading volume, we find that it stood at 401.03 Million shares traded. The 3-month trading volume is 1.13 Million shares.
The consensus among analysts is that BIO-key International, Inc. (BKYI) is a Hold stock at the moment, with a recommendation rating of 3. None of the analysts rate the stock as a Sell, while none rate it as Overweight. 1 out of 1 have rated it as a Hold, with no one of them advising it as a Buy. None have rated the stock as Underweight. The expected earnings per share for the stock is -$0.03.
BIO-key International, Inc. (NASDAQ:BKYI) trade information
Sporting 21.42% in the green today, the stock has traded in the green over the last five days, with the highest price hit on Tuesday, Jun 30 when the BKYI stock price touched $0.91 or saw a rise of 2.2%. Year-to-date, BIO-key International, Inc. shares have moved 78%, while the 5-day performance has seen it change 14.1%. Over the past 30 days, the shares of BIO-key International, Inc. (NASDAQ:BKYI) have changed 19.24%. Short interest in the company has seen 70.71 Million shares shorted with days to cover at 62.58.
Wall Street analysts have a consensus price target for the stock at $2, which means that the shares’ value could jump 124.72% from current levels. The projected low price target is $2 while the price target rests at a high of $2. In that case, then, we find that the current price level is +124.72% off the targeted high while a plunge would see the stock lose 124.72% from current levels.
BIO-key International, Inc. (BKYI) estimates and forecasts
Figures show that BIO-key International, Inc. shares have underperformed across the wider relevant industry. The company’s shares have gained +75.56% over the past 6 months, with this year growth rate of NA%, compared to NA% for the industry. Other than that, the company has, however, increased its growth outlook for the 2020 fiscal year revenue. Growth estimates for the current quarter are 57.1% and 92.3% for the next quarter. Revenue growth from the last financial year stood is estimated to be +144.3%.
1 analysts offering their estimates for the company have set an average revenue estimate of $1.57 Million for the current quarter. 1 have an estimated revenue figure of $1.57 Million for the next quarter concluding in September 01, 2020. Year-ago sales stood $728Million and $453Million respectively for this quarter and the next, and analysts expect sales will grow by 115.7% for the current quarter and 246.6% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -21.8% over the past 5 years. Earnings growth for 2020 is a modest -40.1% while over the next 5 years, the company’s earnings are expected to increase by 0%.